How Epicrispr is leveraging CRISPR without cutting DNA

About this episode

The episode features a discussion with Dr. Stanley Qi about Epicrispr's innovative approach to CRISPR technology that does not involve cutting DNA.

This week we dive into the Beyond Biotech archive to bring you a discussion with Dr Stanley Qi, the founder of Epicrispr. Epicrispr is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells, enabling in vivo or ex vivo delivery via a single viral vector. In this episode we discuss epigenetic editing, why it’s reversible, and how it...

People in this episode

Host: Labiotech

Guest: Dr Stanley Qi

Topics covered

• CRISPR
• epigenetic editing
• Gene Expression Modulation System
• biotechnology
• in vivo delivery

Keywords

• CRISPR
• epigenetic editing
• GEMS
• Cas protein
• viral vector

Mentioned in this episode

Organizations: Epicrispr

More episodes of Beyond Biotech - the podcast from Labiotech

• Advancing corticosteroids and hormonal therapies for supply and scale · June 12, 2026 · 27 min
• Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media · June 5, 2026 · 44 min
• World MS Day Special: Immunic reveals new hope for progressive MS · May 29, 2026 · 28 min
• The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data · May 22, 2026 · 39 min
• Freeze variability, not progress: strengthen your cell therapy supply chain from the start · May 15, 2026 · 30 min
• Making labs smarter for scientific breakthroughs · May 7, 2026 · 31 min